T-Maximum
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed T-Maximum Information
Geographic Data
Address:
City: Suzhou
State: Jiangsu
Zip:
Country: China
Financial Info
Stage:
angel
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors. T-Maximum&s;s gene-editing allogeneic immune cell therapy adopts the version 3.0 program with completely independent intellectual property rights to realize allogeneic universal CAR-T therapy and solve the risk of graft-versus-host disease and rejection of allogeneic immune cells.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2021 | Angel Round | 2 | - |
Haibang Capital Hongfeng Investment Management Haibang Capital Hongfeng Investment Management |
8/2021 | Angel Round | 2 | - |
Haibang Capital Hongfeng Investment Management Haibang Capital Hongfeng Investment Management |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
